GlassScriptPhysician profile
Stephen Grant
NPI 1013026798
$153,011.75
in general payments reported to CMS, 2019-2025
13 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.76 · 2020: $171 · 2021: $586 · 2022: $653 · 2023: $70K · 2024: $54K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $105K · Travel and Lodging: $34K · Food and Beverage: $6,119 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,414 · Consulting Fee: $2,305 · Education: $54.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $105,316.00 |
| Travel and Lodging | $34,357.89 |
| Food and Beverage | $6,118.56 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,414.00 |
| Consulting Fee | $2,304.50 |
| Education | $54.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $136,352.25 | 2019-2025 | |
| Harmony Biosciences LLC | $13,722.17 | 2020-2025 | Wakix |
| Axsome Therapeutics, INC. | $699.72 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $565.73 | 2023-2025 | Lumryz |
| Zoll Respicardia, INC. | $512.81 | 2021-2024 | Remede System |
| Itamar Medical INC | $494.25 | 2022-2024 | Watchpatone |
| Inspire Medical Systems, INC. | $350.09 | 2024-2025 | Inspire |
| Resmed Corp | $110.31 | 2019-2025 | |
| Idorsia Pharmaceuticals US INC | $71.38 | 2023 | Quviviq |
| Fisher & Paykel Healthcare INC | $69.48 | 2022-2024 | Fisher & Paykel Healthcare |
| 3b Medical, INC. | $27.64 | 2025 | Luna |
| Philips North America LLC | $23.49 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.